Latest Health News

Assetora Limited has obtained a Supreme Court injunction restraining external receivers, allowing its directors to maintain control while agreeing on payments to noteholders.

DGL Group Limited has secured an extension of its syndicated debt facility to March 2027 and received a waiver protecting it from default amid its ASX suspension. The company anticipates its securities will be reinstated on the ASX by early 2026 following a half-year audit.

Scout Security outlines a bold transformation with the acquisition of Roo Inc., expansion into insuretech, and a pivot to AI-driven smart security solutions, positioning itself for accelerated growth and profitability.

4DMedical secures Cleveland Clinic as the third major US academic medical centre to adopt its CT – VQ™ respiratory imaging technology, marking rapid commercial traction post-FDA clearance.

Bapcor Limited has obtained unanimous lender approval to temporarily ease its Net Leverage Ratio covenant, supporting its ongoing turnaround efforts through mid-2026.

nib holdings limited signals higher-than-expected non-recurring expenses in the first half of 2026, impacting statutory profit but leaving underlying performance steady.

PeopleIN Limited has announced the sale of its Health and Community brands to Healthcare Australia for $20.25 million, unlocking capital to fuel growth in infrastructure, defence, and agriculture sectors.

PeopleIN Limited has sold its health and aged care staffing arms for $20.25 million, aiming to eliminate net debt and accelerate growth in defence, engineering, and trades sectors.

Epsilon Healthcare Limited has unveiled a comprehensive pre-reinstatement disclosure, highlighting improved financial health and a strategic growth plan focused on operational stability and expansion.

Micro-X Limited has secured $6 million through a share placement to accelerate commercialisation of its innovative medical imaging technologies, with strategic partner Billion Prima increasing its stake to 8.5%. The capital raise supports key clinical trials and product development milestones.

Cleo Diagnostics has raised $5 million to support the U.S. commercial launch of its Pre-Surgical Ovarian Cancer Test and accelerate development of a mass screening test, signaling strong investor confidence in its technology.

Elixinol Wellness has amended acquisition terms for The Healthy Chef after its US distributor exited, reducing earnout payments and refocusing growth efforts on Australia.